Biogen Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€131.80
Target price
31.10.26
€181.48
Performance (%)
24.13%
Price
30.03.26
€163.60
Summary
This prediction is currently active. The prediction currently has a performance of 24.13%. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 3.348% | 3.348% |
| iShares Core DAX® | -1.665% | -10.870% |
| iShares Nasdaq 100 | -3.766% | -5.147% |
| iShares Nikkei 225® | -2.803% | -11.299% |
| iShares S&P 500 | -2.299% | -4.801% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $217.00 to $210.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat